News icon News
Neuron Synapses communicating-firing electrical signals neuroscience

Neurocentrx Reports Positive Top-line Results

Neurocentrx Reports Positive Top-line Results from Phase 1 Clinical Study of its Lead Oral Ketamine Capsule Programme
Read More
News icon News
Neuron Synapses communicating-firing electrical signals neuroscience

Phase I study update

Read More

King’s College

“Working with Neurocentrx has been a most rewarding experience.

“They bring a combination of enthusiasm, professionalism, scientific rigour and sound business sense to projects.

“I really look forward to working with them in the future.”

Professor Allan Young,
Head of School, Academic Psychiatry.
Director, Centre for Affective Disorders,
Institute of Psychiatry, Psychology and Neuroscience (IoPPN)
King’s College London.

Caritas Science Solutions

“It has been a privilege working with the lovely team at Neurocentrx from the start of their journey into clinic, and a joy to have grown and shared successes together over the last couple of years.

“We are proud to support a company which shares our vision and passion to make a difference in mental health, and we look forward to seeing the immense impact they will have in years to come.”

Leigh Fell,
Chief Executive Officer,
Caritas Science Solutions.


“Neurocentrx’s clear communication throughout the trial has been invaluable in making the set-up and running of the trial go smoothly. The team is friendly, personable and respond to any queries in a timely manner.”



“Rapport has been working with the Neurocentrx team as its regulatory partner for six months now.

“They have been very clear regarding their ambitions and accepting of advice and support where needed. We have moved forward very quickly and professionally so that Neurocentrx have the direction they need.”

Lorna Griffin,
Chief Executive Officer,